Claudio R. Alarcón

7.5k citations
16 papers · 6.0k indexed · 4 hit papers · h-index 15
Topics
TGF-β signaling in diseases (8 papers)RNA modifications and cancer (6 papers)Cancer-related gene regulation (4 papers)
Partner nations
United StatesCanadaCuba

In The Last Decade

Claudio R. Alarcón

16 papers receiving 5.9k citations

Hit Papers

Endogenous human microRNAs that suppress breast cancer me...2008202620142020200820152015200950010001.5k

Peers

Claudio R. Alarcón
Comparison fields: 5 of 112
  • Molecular Biology 5.3k
  • Cancer Research 2.7k
  • Oncology 851
  • Cell Biology 466
  • Electrical and Electronic Engineering 313
Replace Michael G. Kharas with:
Michael G. Kharas United States
Monica Fedele Italy
Vincenza Guzzardo Italy
Laurie E. Littlepage United States
Hirotaka Osada Japan
David J. Wong United States
Erik A. Wentzel United States
Álvaro J. Obaya Spain
Nicholas A. Willis United States
Igor Garkavtsev United States
Claudio R. Alarcón relative to Michael G. Kharas United States Michael G. Kharas's profile →
Citations per field
00.5×3.0×
Michael G. Kharas · 1×
Citations per year

Countries citing papers authored by Claudio R. Alarcón

Since Specialization
Citations

This map shows the geographic impact of Claudio R. Alarcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio R. Alarcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio R. Alarcón more than expected).

Fields of papers citing papers by Claudio R. Alarcón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio R. Alarcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio R. Alarcón. The network helps show where Claudio R. Alarcón may publish in the future.

Co-authorship network of co-authors of Claudio R. Alarcón

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio R. Alarcón. A scholar is included among the top collaborators of Claudio R. Alarcón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio R. Alarcón. Claudio R. Alarcón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 14
2 52
3 60
4 63
5
HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Eventsbreakdown →
1188
6
N6-methyladenosine marks primary microRNAs for processingbreakdown →
1089
7
Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathwaysbreakdown →
597
8 306
9
Endogenous human microRNAs that suppress breast cancer metastasisbreakdown →
1527
10 319
11 133
12 217
13 195
14 104
15 17
16 96

About Claudio R. Alarcón

Claudio R. Alarcón is a scholar working on Molecular Biology, Cancer Research and Cell Biology, having authored 16 papers that have together received 6.0k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (8 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cancer Research (2.7k citations), Molecular Biology (5.3k citations) and Oncology (851 citations). Claudio R. Alarcón has collaborated with scholars based in United States, Canada and Cuba. Frequent co-authors include Sohail F. Tavazoie, Joan Massagué, Hani Goodarzi, Hyeseung Lee, Qiongqing Wang, Nils Halberg, Paula D. Bos, David Padua, William L. Gerald and Thórdur Óskarsson. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026